Clinical outcomes of pleural drainage on pneumothorax and hydrothorax in critically ill patients with COVID-19: A case series with literature review

On March 19, 2020, the WHO characterized coronavirus disease 2019 (COVID-19) as a global pandemic. As of Oct 25, 2020, the widespread human-to-human transmission of SARS-CoV-2 has resulted in> 4,2830,000 cases, with> 1,150,000 deaths. The clinical severity of COVID-19 varies greatly, from asymptomatic to death. Pneumothorax and hydrothorax have been reported in patients with COVID-19, especially in critically ill patients. Although it has been suggested that pneumothorax can cause death1 and hydrothorax is a negative prognostic indicator,2 the management of these two conditions is rarely discussed.
Source: Heart and Lung - Category: Intensive Care Authors: Source Type: research